Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2026-04-17 @ 7:45 PM
Study NCT ID:
NCT01748292
Status:
COMPLETED
Last Update Posted:
2019-06-04
First Post:
2012-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
Sponsor:
Charles C Wykoff, PhD, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02
Completion Date Type:
ACTUAL
First Submit Date:
2012-12-07
First Submit QC Date:
None
Study First Post Date:
2012-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-08
Results First Submit QC Date:
None
Results First Post Date:
2017-10-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-15
Last Update Post Date:
2019-06-04
Last Update Post Date Type:
ACTUAL